Nasopharyngeal Carcinoma CTCs Specified Screening
mRNA Circulating Tumor Cells Specified Screening can analyse 30-32 mRNA molecular marker detailedly and access the efficacy of ongoing treatment, postoperative and prognostic tracking in order to investigate a more suitable treatment for the patient. Specially suitable for patient who need to track the Circulating Timor Cells specifically, cancerous person, postoperative cancer tracking and prognostic tracking.
Listed Price is $4,800 and now is $3,000 for the promotional period! Please contact 3168-8188, WhatsApp 6218-8534 or Facebook inbox for more information.
|Nasopharyngeal Carcinoma CTCs Specified ScreeningmRNA-NPCA|
|Analyzing 30-32 mRNA molecular marker detailedly|
|Analyzing the specificity of Tumor|
|Accessing the efficacy of ongoing treatment, postoperative and prognostic tracking|
|Investigating a more suitable treatment for the patient|
|Need to track the Circulating Timor Cells specifically|
|Unhealthy eating, smoking and eating habits|
|Postoperative cancer tracking|
|New Advanced technology- mRNA Circulating Tumor Cells Screening|
|Technology R & D: Eegene International Biotechnology Company Limited|